Enhanced amounts of TIMP-2 protein are found to be associated with prostate cancer malignancies (Ross et al, 2003), but for colon and gastric cancer the correlation with clinico-pathological parameters has not been established (Ring et al, 1997; Joo et al, 2000). The gene discussed is TIMP2; the disease is prostate carcinoma.